ImmunityBio Congress Trades
NASDAQ: IBRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Mar 6, 2023
ImmunityBio Congress trading summary
Members of Congress have disclosed 1 transaction in ImmunityBio (IBRX) stock, reported by 1 politician. No IBRX trades were reported with a transaction date in the past 12 months. The most active trader is Rep. Daniel S. Goldman (1).
The latest reported trade is a sale by Daniel S. Goldman dated Mar 6, 2023 and disclosed on Apr 17, 2023. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading IBRX
IBRX trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Daniel S. GoldmanD-NYHouse | Sell | $1,001 – $15,000 | Mar 6, 2023 | Filing for Daniel S. Goldman IBRX trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell IBRX. How Congress trading data works